Boston, MA 06/10/2013 (wallstreetpr) – The share prices of China Biologic Products Inc. (NASDAQ:CBPO) had declined by 12.89 percent to close at $21.35 per share for the end of last trading session on Friday. The shares of the company had been trading in the range of $19.10 to $24.74 per share during the day. The shares of China Biologic Products Inc. (NASDAQ:CBPO) had recorded 52 week low price level of $8.00 per share and 52 week low price level of $31.15 per share.
China Biologic Products Inc. (NASDAQ:CBPO) is primarily engaged in the development and commercialization of human plasma based pharmaceutical products through its wholly owned subsidiaries in People’s Republic of China. The company sells its products to customers through independent distributors and through hospitals and inoculation centers.
China Biologic Products Inc. (NASDAQ:CBPO) had recently announced that it had received notice from the Hong Kong solicitors related to a pending litigation for the title dispute of shares held by an individual shareholder of the company Ms. Siu Ling Chan. The Plaintiffs who obtained the injunction order had thereby prohibited the individual shareholder from disposing of, charging, encumbering, pledging, transferring and diminishing the value of the shares held by her.
China Biologic Products Inc. (NASDAQ:CBPO) presently holds 26.85 million shares outstanding in the market with an institutional ownership of 32 percent of its holdings. The company witnessed the trade of 183,303 shares on the last trading session of Friday, while the average trading volume of China Biologic Products Inc. (NASDAQ:CBPO) is at 25,316 shares per day.
